Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

945

Participants

Timeline

Start Date

July 24, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

February 12, 2019

Conditions
Influenza
Interventions
BIOLOGICAL

GPO Tri Fluvac vaccine

The vaccine will be administered via the intramuscular route; the preferred injection site will be the deltoid of the non-dominant arm.

BIOLOGICAL

Licensed influenza vaccine

The comparator licensed influenza vaccine will be administered via the intramuscular route; the preferred injection site will be the deltoid of the non-dominant arm.

Trial Locations (2)

10400

Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University,, Bangkok

Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok

All Listed Sponsors
collaborator

The Government Pharmaceutical Organization

OTHER_GOV

collaborator

World Health Organization

OTHER

lead

Mahidol University

OTHER

NCT03390166 - Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults | Biotech Hunter | Biotech Hunter